A B ST R A C T The metabolic response to the first fast experienced by all mammals has been studied in the newborn rat. Levels of fuels and hormones have been compared in the fetal and maternal circulations at term. Then, after cesarean section just before the normal time of birth, sequential changes in the same parameters were quantified during the first 16 h of the neonatal period. No caloric intake was permitted, and the newborns were maintained at 370C. Activities of three key hepatic enzymes involved in glucose production were estimated.
the fetus. Pyruvate, glutamate, and ketone bodies were not significantly different. The combination of a strikingly higher fetal immunoreactive insulin and a slightly lower immunoreactive glucagon (pancreatic) resulted in a profound elevation in the insulin-to-glucagon ratio, a finding consistent with an organism in an anabolic state.
The rat at birth presents a body composition with respect to fuels available for mobilization and conversion which is dominated by carbohydrate and protein, since little fat is present. However, at birth a transient period of hypoglycemia occurred, associated with a rapid fall in insulin and rise in glucagon, causing reversal of the insulin-to-glucagon relationship toward ratios such as were observed in the mother. After a lag period, hepatic activities of phosphorylase, glucose-6-phosphatase, and phosphoenolpyruvate carboxykinase increased. Concurrent with these enzyme changes, the blood glucose returned to levels at or above those of the INTRODUCTION The interruption of the continuous transplacental fuel supply to the fetus at birth imposes a completely altered metabolic environment upon the newborn. It must rapidly convert from a long-term "fed" to an absolute "fasted" situation, not only to survive the neonatal period, but to establish lifelong mechanisms for the adaptation to the alternating feeding and fasting of extrauterine life. Acutely, however, it must make oxidative fuel available from endogenous reserves until commencThe Journal of Clinical Investigation Volume 52 December 1973 -3190-3200 ing alimentation in the form of milk from the mother. In the rat, this period of 4-6 h is invariably associated with profound hypoglycemia, spontaneously returning toward normoglycemia by 4 h (1) (2) (3) (4) . This occurs whether birth is spontaneous at term or by cesarean section near the end of gestation (2, 3) . Glucose, the principal intrauterine oxidative fuel, must therefore be produced from liver glycogen stores or via de novo synthesis from lactate, pyruvate, glycerol, and amino acids.
It is well-established that in the rat the fetal liver accumulates large glycogen stores, which are rapidly mobilized after birth (1, (3) (4) (5) . By contrast, the capacity for gluconeogenesis is acquired only postpartum (5, 6) . The mechanisms of postnatal activation of metabolic pathways for glycogenolysis and gluconeogenesis have not been fully elucidated.
A role for glucagon in these processes has been proposed (1, 2) . Indeed, it has recently been demonstrated that plasma glucagon levels rise during the early postnatal period in the rat (4, 7) . However, glucose homeostasis in vivo (8) and hepatic metabolism in vitro (9) (10) (11) in mature animals appear to be determined principally by the interaction of insulin and glucagon levels. For example, the disposition of gluconeogenic amino acids into hepatic glucose production versus muscle protein synthesis is probably determined by such an interaction (12, 13) . It has been suggested that adipose tissue fuel balance may be determined likewise (14) .
In light of such observations, the present study was performed to correlate secretion of insulin and glucagon with the changes observed in metabolites during the early postnatal fasting period. Since growth hormone has effects which would render it an appropriate fasting hormone, its levels have also been determined. Further, the activities of certain key hepatic enzymes have been assayed and correlated with the hormone-substrate alterations. Hence the data presented represent corroboration of the findings of a number of previous investigators, but in a context which allowed for simultaneous correlations among levels of circulating fuels, hormones, and hepatic enzyme activities. [10] [11] [12] in number) were immediately transferred to a "humidicrib" (Jouan, S. A., Paris) in which temperature was maintained at 370C and relative humidity at 70%. They remained unfed for the whole of the present study.
METHODS
Blood was sampled via an incision across the axillary vessels after careful cleaning of the axillary region. For the data designated as "fetal," the pregnant rat was anesthetized by 30 (9) 8.0±0.8 (12) 0.01 Plasma immunoreactive glucagon pg/ml 560±40 (10) 270±29 (18) 0.01 Plasma growth hormone ng/ml 103±+19 (12) 147t±8 (29) (27) . The inorganic phosphate released was assayed by the procedure of Fiske and Subbarow (28) . Phosphorylase (EC 2.4.1.1) was similarly assayed in crude homogenates with a modification of the procedure of Cake and Oliver (29 captoethanol, at pH 6.5. Protein was determined by the biuret method (30) .
Statistical analyses were performed using the Student unpaired t test, to establish the significance of changes with time in the parameters studied.
Hormowe assays. Plasma insulin concentrations (IRI) were estimated using a radioimmunoassay system separating bound and free hormone with uncoated charcoal (31), an anti-insulin serum reacting poorly with proinsulin, and purified rat insulin as standard (lot R169, 24 U/mg, supplied by Novo Research Institute, Copenhagen). Plasma immunoreactive glucagon (IRG) was determined with a pancreatic-glucagon-specific antibody K47, kindly supplied by L. G. Heding (Novo Research Institute) in an assay system described previously (4). The assay for glucagon is considered to provide values representing immunoreactivity originating primarily on the pancreas. This is based upon data demonstrating the poor cross-reactivity of the antiserum employed, with gut extracts (32) . Although the antiserum K47 has been shown to react to some extent with pancreatic glucagon fragments, it gives absolute values for human plasma consistent with those of other pancreaticglucagon-specific antisera, and these values decline after oral glucose load (32) .
Growth hormone levels in plasma were also measured by radioimmunoassay using an uncoated charcoal separation technique (33) The responses of circulating energy substrates and hormones from delivery to 16 h of extrauterine life are presented in Fig. 14 The composition of circulating substrates in the fetus similarly demonstrated a predominance of carbohydrate and amino acids. These are shown in Table I , where maternal arterial levels are shown for comparison. Of note are the markedly higher fetal lactate, a-amino nitrogen, glutamine, alanine, and IRI, and slightly higher growth hormone levels. By contrast, concentrations of glucose, FFA, glycerol, and IRG were much lower in the fetus. The ketone bodies (acetoacetate and 9-hydroxybutyrate) and glutamate levels were similar in fetal and maternal circulations. With reference to the metabolic state of the pregnant rats, it is of interest to note that the observed levels of IRG and growth hormone exceeded those of fed virgin rats of equivalent age, though insulin levels were not different. Values for virgin rats with equivalent blood glucose concentrations were: IRI 0.85±0.06 ng/ml (n= 6), IRG 200±20 pg/ml (n = 6), insulin/glucagon molar ratio 2.4, growth hormone 28±4 ng/ml (n = 8).
'Ricquier, D., and P. Hemon. Personal communication. 16 h. The insulin/glucagon molar ratio was high in the fetus, fell precipitously during the 1st h, then remained low (Fig. 4) . Growth hormone levels, high in the fetus, rose even higher to 0 time and at 30 min postpartum, then showed a significant (P < 0.02) transient decline at 1 h. No clear trend in either direction occurred after 1 h (Table II) .
During the period of falling blood glucose, IRI, and gluconeogenic substrate levels, and of the rise in IRG, striking changes in liver glycogen (Table III) and enzyme activities (Table IV) DISCUSSION During gestation, the unremitting maternal supply of substrates and cofactors is directed toward synthetic processes, for which the energy supply is principally from glucose oxidation. Before term, some glucose is diverted to hepatic lipogenesis and part is stored as glycogen in muscle, heart, and liver (34) . Though fetal plasma amino acid levels are extremely elevated (they are transported across the placenta against a concentration gradient [35] ), the nonruminant mammalian fetus appears unable either to oxidize them or to convert them to glucose (36) . In the rat, the absence of white adipose tissue, the low triglyceride content of brown adipose tissue, and the relative impermeability of the placenta to FFA (35) probably account for the low fetal FFA and glycerol levels. Furthermore, the fetal liver has a low capacity for ketogenesis (37) (38) (39) at concentrations approximating maternal blood, suggesting free transplacental transfer (35) . Since fetal tissues can derive energy from ketone bodies (41, 42) , these are alternate fuels, which may be utilized during times of maternal glucopenia. Hormone levels in the term fetus would appear appropriate to the maximally anabolic state. The extremely high IRI (43) and low levels of glucagon (7, 44) create an insulin-glucagon relationship which in the adult is considered to favor anabolism (8) . (It is of note that the observed maternal insulin/glucagon molar ratio would favor catabolism, which in the gravid organism would be appropriate for provision of substrate to the fetus [45] .) The significance of the high fetal growth hormone levels is unclear, since normal growth of the rat fetus occurs in the absence of this hormone (34) .
The postnatal activation of hepatic enzymes critical for glucose production has been demonstrated previously (1, 2, 5, 29). Though it was postulated that glucagon (and catecholamine) secretion might be responsible, this was not previously correlated temporally with enzyme changes. Substrate levels and Michaelis constants (Kni) of the enzymes studied are such that increase in activity as assayed in the previous and present studies would be expected to produce increased glucose output (5) . The period between birth and recovery from hypoglycemia corresponds to the time course of the increases in enzyme activity. Such findings in rats have been reported previously for phosphorylase (4, 29), glucose-6-phosphatase (1), and PEPCK (5, 6). Equivalent changes have been shown in other species (42) .
Several lines of evidence support a role for glucagon in the induction of the observed changes in hepatic metabolism. First, the rise in endogenous IRG levels preceded the hepatic changes. Second, exogenous glucagon administered to fetal rats in utero has been shown to be capable of provoking premature glycogen degradation (46) (47) (48) , increasing activities of glucose-6-phosphatase (49, 50), PEPCK (2, 51), and phosphorylase (3, 50) . The third suggestive line of evidence is the hypoaminoacidemic effect of exogenous glucagon in the fetus' as well as the adult (10, 12) . Fourth, the glucagon induction of autophagocytosis due to increased lysosomal activity has been shown in the adult rat liver (52) , and such changes occur spontaneously after birth (53) . Fifth, a marked increase in liver 3',5'-cyclic AMP has been demonstrated after birth, which would be expected with increased endogenous glucagon, particularly if associated with decrease in the insulin/glucagon ratio (53, 54) . It is probable that any one or a combination of such glucagon-mediated effects could be inhibited by insulin (10) . Thus the concurrent fall in IRI levels and in insulin/glucagon ratio probably contributed significantly to the changes observed.
Increased activity of the autonomic nervous system at birth, acting via epinephrine secretion or local norepinephrine release could equally influence hepatic glucose release, and stimulate lipolysis in adipose tissue. Evidence for its role in mobilization of hepatic glucogen has been presented in the newborn calf (55 a contribution of glucose by the kidney (though renal gluconeogenic capacity is reportedly low at this stage) (58) and a decrease in glucose utilization (57) . The distribution of the increased hepatic glucose output between glycogenolysis and gluconeogenesis has not been quantified. According to Snell and Walker (57) and to Ballard (5) the rate of glucose utilization in such newborn rats is 10-15 nmol/h. At maximal rates, gluconeogenesis (using lactate as precursor) could account for only 15% of the glucose required in the 4 h old newborn rat (5) . The sharp decrease in glucogenic precursors observed even before the rise in glycemia would appear to be at variance with such a calculation. For lactate, the initial fall in levels may be attributed to rates of utilization and conversion to glucose in excess of production rates (57) . Lactate was the substrate most readily converted to glucose in liver slices from newborn rats (58) . The initial hypoaminoacidemia could be due to increase in hepatic uptake, perhaps with continuing peripheral uptake. The fall in alanine, in particular, might be related to hepatic uptake (36, 58, 59) and diminished muscle output owing to decreased glycolysis. In addition, there may be a more rapid hepatic uptake than conversion to glucose, with net intracellular substrate accumulation (60) . The suggestion that such accumulation might be related to the activity of transaminases is raised by the data of Reisner et al. (61) .
Thus, both recovery from the first, and the development of the second period of hypoglycemia probably relate to the mobilization of liver glycogen. According to the reported rates of glucose utilization, glycogenolysis would be sufficient to maintain euglycemia only up to 10 h. The rise in plasma levels of amino acids at 16 h though hypoglycemia persists, implies that gluconeogenesis is not sufficient at this stage to maintain blood glucose levels, as previously suggested by Ballard (5) , despite a further rise in glucagon levels.
It is noteworthy that similar trends in levels of glucose and precursors have been reported in newborn rats, though with some differences in absolute values likely attributable to variations in protocol ('7, 36, 57, 62) . Such variations include the use of differing strains of rats; altered maternal diet; the use of newborns after spontaneous parturition; study of newborns at temperatures other than 370C; and use of whole blood rather than plasma for certain of the substrate assays.
The slight rise in FFA and the transient rise in glycerol might be attributable to lipolysis in brown adipose tissue. However, the primary stimulus to lipolysis in this tissue is local norepinephrine release, particularly in response to cold exposure. Hence, lipid mobilization might have been inhibited by maintaining the newborns at thermal neutrality. The decrease observed in blood glycerol starting 2 h after birth might be attributable in part to its conversion to glucose (63) . The fall in blood P-hydroxybutyrate with no change in acetoacetate cannot be explained by the data available. The late rise in ketone body levels at a time of falling FFA levels suggest more active conversion of fatty acids to ketones, which might serve as alternate nervous system energy substrates in the presence of hypoglycemia (64) .
The control of the insulin and glucagon secretory changes observed has not been defined by the present study. Though the early cataglycemia would be expected to induce the early decrease in IRI and increase in IRG, it is likely that it is not the primary mediator because newborn #-and a-cells are remarkably unresponsive to changes in glycemia (44, 65, 66) . If the high amino acid levels are to be implicated in islet cell function, it is difficult to account for the low fetal IRG Early Postnatal Hormones, Fuels, and Liver Metabolism warilh high amino acid levels, and rise in IRG while plasma amino acids fall in concentration. The relation between changes in plasma amino acids and IRI secretion would be more appropriate, since the newborn i-cell is responsive to these substances (67) .
A further mechanism to account for changes in levels of both hormones might be the activity of the autonomic nervous system. The stress of removal of the fetus from the intrauterine environment undoubtedly augments sympathetic activity, which has been shown in the adult organism to stimulate IRG (68) and inlhibit IRI (69) release. Furthermore, the administration of norepinephrine to the term fetus raises IRG and lowers IRI levels (44) .5 The second rise in IRG at 16 h is also not explained, but in this instance hypoglycemia developing over the preceding 10 h might be responsible. Neural stimulation may be responsible as well for the acute rise in growth hormone levels between fetal and immediate newborn periods, though an effect of the maternal anesthesia used in obtaining fetal samples is not excluded.
Observations upon the metabolic state of the rat at birth may not be directly extrapolated to other mammals, because of a number of peculiar features of this species, including absent white adipose tissue, primary energy store in the form of glycogen, and very high basal metabolic rate. However, both a decrease in glycemia and an increase in IRG have been reported in the human newborn (70, 71) . The secretory behavior of the human a-cell at birth may thus be relevant to normal extrauterine adaptation, and altered secretion may contribute to abnormal states of glucoregulation demonstrated in the infants of diabetic mothers. The reported failure of glucagon release (71) might be associated with delay in neonatal maturation of hepatic mechanisms for glucose production. In addition, the "small-for-dates" newborn is characterized by lack of adipose tissue and is subject to hypoglycemia for which the pathophysiology is as yet incompletely defined. The present model could provide potential insights into the mechanism of disturbed fuel homeostasis in this state.
